secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001809519-24-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx interim CEO Scott Wagner extends commitment; two board directors resign
------------------------------------------------------------------------------

- Scott Wagner's employment agreement revised to indefinite term, annual cash bonus target 100% of base salary.
- Wagner granted $8M in equity ($4M options, $4M RSUs) vesting monthly over eight months starting May 8, 2024.
- Stephen LeSieur resigns from board effective March 14, 2024; Adam Karol resigns effective March 22, 2024.
- Both directors cited no disagreement; LeSieur departure follows repurchase of Spectrum shares from him.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/0001809519-24-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000048/gdrx-8xkxitem502x701x901in.htm
  HTML page:      https://secwatch.observer/filing/0001809519-24-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer